This compound is a pharmaceutical intermediate used in the synthesis of bexarotene impurities. It features a substituted naphthalene ring system with an ethenyl-linked phenyl ethanone group, giving it a rigid, aromatic structure with moderate polarity.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1349659-53-5
Bexarotène
antioneoplastic active pharmaceutical ingredient
Methyl 4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)benzoate
Bexarotene impurity reference standard
2-[2-(2-aminoethoxy)ethoxy]acetic acid;hydrochloride
Pharmaceutical intermediate for pegylation
(1S,5R)-8-Methyl-8-Azabicyclo(3.2.1)Octan-3-Ol
pharmaceutical intermediate
Dibenzyl (2S,4R)-4-hydroxypyrrolidine-1,2-dicarboxylate
protected proline derivative for peptide synthesis
Febuxostat impurity 7
Pharmaceutical impurity reference standard
1-[4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]phenyl]ethanone
SJDZRZNTLQWQAH-UHFFFAOYSA-N
CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)C)C(CCC2(C)C)(C)C
—